Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

33
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
33
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

997
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
997
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revue medicale suisse·2026
Same author

Early Repolarization in Young Athletes: Prevalence and Sex-Specific Patterns.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine·2026
Same author

Cardiac arrhythmia during cold-water immersion: a self-controlled field study with extended rhythm monitoring.

Journal of exercise science and fitness·2026
Same author

Revue medicale suisse·2026
Same author

[Addictions : what's new in 2025].

Revue medicale suisse·2026
Same author

Catheter ablation of atrial fibrillation: time to look beyond iterative pulmonary vein isolation only and "one-size-fits-all" strategies.

Indian pacing and electrophysiology journal·2025

Related Experiment Video

Updated: Jul 15, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K

[Atrial fibrillation: 2023 novelties for the general practitioner].

Zoe Koull1, Alienor Conus1, Mehdi Namdar2

  • 1Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.

Revue Medicale Suisse
|September 27, 2023
PubMed
Summary

Atrial fibrillation (AF), a common heart rhythm disorder, is diagnosed using ECGs and increasingly with smartwatches. A new 4S scheme aids evaluation, guiding treatments like catheter ablation and risk factor management for better patient outcomes.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.7K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.7K

Related Experiment Videos

Last Updated: Jul 15, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.7K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.7K

Area of Science:

  • Cardiology
  • Medical Technology

Context:

  • Atrial fibrillation (AF) is the most prevalent tachyarrhythmia, associated with substantial morbidity and mortality.
  • Traditional diagnosis relies on the 12-lead electrocardiogram (ECG).
  • Emerging wearable technologies demonstrate comparable diagnostic accuracy to standard ECGs.

Purpose:

  • To introduce the 4S scheme (Stroke risk, Symptoms, Severity of AF burden, Substrate) for comprehensive AF evaluation.
  • To highlight the increasing role of rhythm control strategies, particularly catheter ablation.
  • To emphasize the critical importance of managing cardiovascular risk factors in AF patients.

Summary:

  • The 4S scheme provides a holistic approach to assessing patients with atrial fibrillation.
  • Diagnosis can be effectively achieved through both traditional ECG and newer connected watch technologies.
  • Rhythm control, including catheter ablation, is a key therapeutic intervention.

Impact:

  • Improved diagnostic capabilities through advanced technology integration.
  • Enhanced patient management strategies incorporating risk stratification and personalized treatment.
  • Potential for reduced morbimortality associated with atrial fibrillation through comprehensive care.